| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8744765 | Clinical Microbiology and Infection | 2018 | 24 Pages |
Abstract
According to our single-centre experience, patients with MM and lymphoma undergoing AHCT may benefit from antibacterial prophylaxis with ciprofloxacin.
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
M. Yeshurun, I. Vaxman, L. Shargian, D. Yahav, J. Bishara, O. Pasvolsky, O. Wolach, M. Lahav, R. Gurion, H. Magen, L. Vidal, C. Herscovici, A. Peck, M. Moshe, M. Sela-Navon, E. Naparstek, P. Raanani, U. Rozovski,